News

KRN5500 is a non-narcotic, non-opioid, analgesic agent produced by Streptomyces alanosinicus. According to the Phase II, double-blind, placebo-controlled, randomized, dose escalation study, KRN5500 showed significant improvement in the

The contract also supports the research on plasminogen activator (TPA) and Silabilin as MCM’s against sulfur mustard gas exposure. AEOL can also be used to treat pulmonary injuries

The new project which is worth $3.5m will lay emphasis on manufacturing pharmaceutical and medical device products. The company said the move has been made following a rise

Postherpetic neuralgia (PHN) is referred to the pain following healing of the rash associated with shingles. Gralise is available as a prescription drug in a 30-day starter pack,

The double-blind, placebo-controlled and randomized trial which enrolled 100 patients was designed to assess the efficacy and safety of the talactoferrin in patients with previously treated non-small cell

Bexarotene capsules are used to treat cutaneous T-cell lymphoma (CTCL skin cancer) and are a generic version of Targretin. Following FDA approval, the company expects to qualify for

During the course of the trial, 4.5mg/ml doses of Aimspro was administered subcutaneously twice weekly for 26 weeks and its efficacy was evaluated as compared to a placebo.

As per the deal, VGX International will receive marketing rights for the vaccines in Asia, except Japan, and will fund IND-enabling and initial phase I and II clinical

Ampion is a small molecule with non-steroidal anti-inflammatory and analgesic properties that is naturally produced by humans in response to injury. The molecule is formed from the cleavage